Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: March 31, 2016 ~ The Lancet Respiratory Medicine in conversation with Podcast

Michael Kreuter discusses a pooled analysis of data on the role
of antacid therapy in the progression of idiopathic pulmonary
fibrosis.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: March 31, 2016

Beschreibung

Weitere Episoden

Joan Soriano on Global Epidemiology of Respiratory Disease

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

Laura Garriga-Grimau on bronchiectasis in children and young people

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

Kommentare (0)

Abonnenten

Anmelden mit